Market Research Logo

Pharmaceuticals in South Africa

Pharmaceuticals in South Africa

Summary

Pharmaceuticals in South Africa industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the South Africa pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

  • The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
  • The South African pharmaceuticals market had total revenues of $6.6bn in 2017, representing a compound annual growth rate (CAGR) of 5% between 2013 and 2017.
  • Generics will continue to be a popular choice in South Africa given its aging population and increased education to the public on the importance of a proactive approach to their own healthcare.
  • The government is attempting to increase the growth rate of the pharmaceutical industry. The introduction of the South African Health Products Regulatory Authority (SAHPRA) in June 2017 has been part of this effort.
Scope
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in South Africa
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in South Africa
  • Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the South Africa pharmaceuticals market with five year forecasts
Reasons to buy
  • What was the size of the South Africa pharmaceuticals market by value in 2017?
  • What will be the size of the South Africa pharmaceuticals market in 2022?
  • What factors are affecting the strength of competition in the South Africa pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitiors in South Africa's pharmaceuticals market?


Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Adcock Ingram Holdings Ltd
Aspen Pharmacare Holdings Ltd
Novartis AG
Sanofi SA
Macroeconomic Indicators
Country data
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine
List of Tables
Table 1: South Africa pharmaceuticals market value: $ billion, 2013-17
Table 2: South Africa pharmaceuticals market geography segmentation: $ billion, 2017
Table 3: South Africa pharmaceuticals market share: % share, by value, 2017
Table 4: South Africa pharmaceuticals market value forecast: $ billion, 2017-22
Table 5: Adcock Ingram Holdings Ltd: key facts
Table 6: Adcock Ingram Holdings Ltd: key financials ($)
Table 7: Adcock Ingram Holdings Ltd: key financials (ZAR)
Table 8: Adcock Ingram Holdings Ltd: key financial ratios
Table 9: Aspen Pharmacare Holdings Ltd: key facts
Table 10: Aspen Pharmacare Holdings Ltd: key financials ($)
Table 11: Aspen Pharmacare Holdings Ltd: key financials (ZAR)
Table 12: Aspen Pharmacare Holdings Ltd: key financial ratios
Table 13: Novartis AG: key facts
Table 14: Novartis AG: key financials ($)
Table 15: Novartis AG: key financial ratios
Table 16: Sanofi SA: key facts
Table 17: Sanofi SA: key financials ($)
Table 18: Sanofi SA: key financials (€)
Table 19: Sanofi SA: key financial ratios
Table 20: South Africa size of population (million), 2013-17
Table 21: South Africa gdp (constant 2005 prices, $ billion), 2013-17
Table 22: South Africa gdp (current prices, $ billion), 2013-17
Table 23: South Africa inflation, 2013-17
Table 24: South Africa consumer price index (absolute), 2013-17
Table 25: South Africa exchange rate, 2013-17
List of Figures
Figure 1: South Africa pharmaceuticals market value: $ billion, 2013-17
Figure 2: South Africa pharmaceuticals market geography segmentation: % share, by value, 2017
Figure 3: South Africa pharmaceuticals market share: % share, by value, 2017
Figure 4: South Africa pharmaceuticals market value forecast: $ billion, 2017-22
Figure 5: Forces driving competition in the pharmaceuticals market in South Africa, 2017
Figure 6: Drivers of buyer power in the pharmaceuticals market in South Africa, 2017
Figure 7: Drivers of supplier power in the pharmaceuticals market in South Africa, 2017
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in South Africa, 2017
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in South Africa, 2017
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in South Africa, 2017
Figure 11: Adcock Ingram Holdings Ltd: revenues & profitability
Figure 12: Adcock Ingram Holdings Ltd: assets & liabilities
Figure 13: Aspen Pharmacare Holdings Ltd: revenues & profitability
Figure 14: Aspen Pharmacare Holdings Ltd: assets & liabilities
Figure 15: Novartis AG: revenues & profitability
Figure 16: Novartis AG: assets & liabilities
Figure 17: Sanofi SA: revenues & profitability
Figure 18: Sanofi SA: assets & liabilities

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report